slider-major-shareholders.png
Patent news - Japan

Ovoca Bio plc is pleased to announce that on 2nd September 2019 its subsidiary, IVIX, received patent No 6552960 in Japan covering pharmaceutical use for a list of peptide variants based on BP-101.

September 4, 2019
More...
BIO 2019 Press Release

The 37th BIO International Convention in Philadelphia, United States.

June 15, 2019
More...
Ovoca Presents at BIO 2019 International Convention, Philadelphia

Ovoca Presents at BIO 2019 International Convention, Philadelphia

May 31, 2019
More...
Patent news - Israel

Ovoca Bio plc is pleased to announce that on 1st March 2019 its subsidiary, IVIX, was granted patent No 234753 in Israel covering any use for a large list of peptide variants based on BP-101.

May 7, 2019
More...
US AND EU CLINICAL DEVELOPMENT PLANS

Ovoca Bio plc is pleased to announce that its subsidiary IVIX has commenced the process of preparing an integrated Clinical Development Plan (“CDP”) for its investigational drug candidate, Libicore (BP-101), for both the US and EU regions with Biorasi LLC (“Biorasi”), an experienced US-based contract research organization.

April 23, 2019
More...
Ovoca Presents at BIO-Europe Spring® 2019, Vienna

Ovoca Presents at BIO-Europe Spring® 2019, Vienna

April 15, 2019
More...
Ovoca is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany)

Ovoca is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany), an experienced biopharmaceutical drug development consultancy firm, to provide regulatory affairs services.  

October 10, 2018
More...
Completion of the Acquisition of IVIX

Ovoca is pleased to announce that on 25th of September 2018 the notary public notified the Company that its subsidiary, Silver Star Ltd., has been formally registered on the Russian Unified State Register of Legal Entities as the owner of ...

September 26, 2018
More...
Annual General Meeting and Extraordinary General Meeting

On 27th of July 2018, Ovoca Gold Plc held Annual General Meeting and Extraordinary General Meeting in Radisson Blu St Helen hotel in Dublin, as it was announced on 4th of July 2018.

July 27, 2018
More...